{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:06:43Z","timestamp":1773234403432,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.4158\/ep11081.cr","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T21:07:22Z","timestamp":1311973642000},"page":"e101-e103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Orbital Inflammatory Disease in A Patient Treated with Zoledronate"],"prefix":"10.1016","volume":"17","author":[{"given":"Harpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Uy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold M.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP11081.CR_bb0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archopht.121.9.1335","article-title":"Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer","volume":"121","author":"Subramanian","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.4158\/EP11081.CR_bb0015","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11081.CR_bb0020","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1210\/jc.2010-0597","article-title":"Characterization of and risks for the acute-phase response after zoledronic acid","volume":"95","author":"Reid","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP11081.CR_bb0025","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMc0803366","article-title":"Zoledronic acid infusion and orbital inflammatory disease","volume":"359","author":"Sharma","year":"2008","journal-title":"N Engl J Med"},{"key":"10.4158\/EP11081.CR_bb0030","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/archophthalmol.2007.17","article-title":"Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal carcinoma","volume":"126","author":"Phillips","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.4158\/EP11081.CR_bb0035","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00198-009-1048-1","article-title":"Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis","volume":"21","author":"Procianoy","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP11081.CR_bb0040","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/rheumatology\/40.8.956","article-title":"Idiopathic orbital inflammation following intravenous pamidronate","volume":"40","author":"Ryan","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.4158\/EP11081.CR_bb0045","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJM200303203481225","article-title":"Bisphosphonates and ocular inflammation","volume":"348","author":"Fraunfelder","year":"2003","journal-title":"N Eng J Med"},{"key":"10.4158\/EP11081.CR_bb0050","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12032-007-9006-2","article-title":"A case report: zoledronic acid-induced anterior uveitis","volume":"25","author":"Kilickap","year":"2008","journal-title":"Med Oncol"},{"key":"10.4158\/EP11081.CR_bb0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.clon.2006.04.013","article-title":"Serious ocular complications of zoledronate","volume":"18","author":"Woo","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20417744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20417744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/07R8740708Q87711.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:53:31Z","timestamp":1761515611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20417744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1530891X20417744"],"URL":"https:\/\/doi.org\/10.4158\/ep11081.cr","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orbital Inflammatory Disease in A Patient Treated with Zoledronate","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP11081.CR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}